PRIVACY & SECURITY FORUM: A HIMSS EVENT
Boston, MA - December 5 - 7, 2016
Dr. Khaled El Emam is the founder Privacy Analytics Inc. As an entrepreneur, Khaled helped found five companies involved with data management and data analytics. He has worked in technical and management positions in academic and business settings in England, Scotland and Japan.
Khaled is also a senior scientist at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute and Director of the multi-disciplinary Electronic Health Information Laboratory (EHIL) team, conducting academic research on de-identification and re-identification risk. He is a world renowned expert in statistical de-identification and re-identification risk measurement. He is one of only a handful of individual experts in North America qualified to anonymize Protected Health Information under the HIPAA Privacy Rule.
In 2003 and 2004, Khaled was ranked as the top systems and software engineering scholar worldwide by the Journal of Systems and Software based on his research on measurement and quality evaluation and improvement.
Previously, Khaled was a Senior Research Officer at the National Research Council of Canada. He also served as the head of the Quantitative Methods Group at the Fraunhofer Institute in Kaiserslautern, Germany.
Khaled was one of the first Privacy by Design Ambassadors recognized by the Ontario Information and Privacy Commissioner. He previously held the Canada Research Chair in Electronic Health Information at the University of Ottawa and was an Associate Professor in the Faculty of Medicine at the University. He has a PhD from the Department of Electrical and Electronics Engineering, King’s College, at the University of London, England.
The secondary use of personal health data can transform healthcare quality and medical innovation, but is only possible with consent or the data being fully de-identified. The application of new risk-based privacy techniques now make de-identification possible at a global scale. While privacy is the responsibility of all healthcare organizations, life-science companies and data leaders (real-world evidence) are driving and benefiting from the implementation of new global privacy standards in the health data sharing space. Leading companies are building dedicated data platforms in specific disease areas that extend across multiple countries and encompass sophisticated data collections and technology-enabled analytics. This talk explores the topic of maintaining privacy when leveraging data.